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Abstract Erythrochelin, a hydroxamate-type siderophore produced by 
Saccharopolyspora erythraea, is synthesized for the first time. A key 
building block of erythrochelin containing the 2,5-diketopiperazine ring is 
prepared by intramolecular cyclization of the corresponding dipeptide 
precursor derived from two kinds of protected δ-N-hydroxy-L-ornithines. 
Consecutive condensation of the building block with protected D-serine 
and protected δ-N-hydroxy-D-ornithine, followed by deprotection, 
furnishes erythrochelin. 
Key words erythrochelin, rhodotorulic acid, siderophore, 2,5-
diketopiperazine, electrospray ionization mass spectrometry 
Erythrochelin (1)1, a hydroxamate-type tetrapeptide 
siderophore2, was isolated as the first nonribosomal peptide 
synthetase (NRPS)-derived natural product of 
Saccharopolyspora erythraea.3 In 2010, two groups 
independently reported the isolation and structural 
characterization of 1 (Figure 1).4 Marahiel et al. identified the 
structure of 1 using a novel radio-LC-MS–guided genome 
mining methodology as well as NMR and MS analyses.1a On the 
other hand, Leadlay et al. isolated 1 as the metabolic product of 
the cryptic NRPS cluster and determined the structure based 
on NMR analysis of the Ga(III) complex of 1.1b Both groups 
proposed that the chemical structure of 1 included a 2,5-
diketopiperazine (2,5-DKP) ring derived from δ-N-acetyl-δ-N-
hydroxy-L-ornithine and δ-N-hydroxy-L-ornithine. In addition, 
a dipeptide moiety comprised of D-serine and α-N-acetyl-δ-N-
acetyl-δ-N-hydroxy-D-ornithine was presented. In the 
literature, a biosynthetic route was established in vitro for the 
generation of δ-N-acetyl-δ-N-hydroxy-L-ornithine starting from 
L-ornithine.5 However, there has been no report on the 
chemical synthesis of 1, and the specific rotation value of 1 has 
not been established. 
Figure 1  Chemical structures of erythrochelin (1), foroxymithine (2), and 
rhodotorulic acid (3). 
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Scheme 1  Synthesis of 2,5-DKP 9.
In 1985, foroxymithine (2), which has a very similar chemical 
structure to 1, was isolated from cultures of Streptomyces 
nitrosporeus as an angiotensin-converting enzyme inhibitor.6 
Interestingly, 2 was constructed from only L-α-amino acids, 
whereas corresponding L- and D-α-amino acids were contained 
in 1 as shown in Figure 1. Dolence and Miller achieved the total 
synthesis of 2.7 They established the chemical structure of 2 by 
comparing the spectroscopic data, including the specific 
rotation, with that of the natural product. The stereochemical 
structure of 2 isolated from Streptomyces narbonensis was also 
confirmed by Marfey’s analysis of the corresponding Ga(III) 
complex of 2.8 The biosynthetic mechanism of 2 has been 
predicted based on the NRPS domain organization.9 In 
addition, rhodotorulic acid (3)10, a structurally related 
hydroxamate-type siderophore isolated from Rhodotorula 
pilimanae, has been synthesized by several groups, including 
ours.11 A series of siderophores—triornicin,12 isotriornicin,13 
dimerumic acid,14 coprogen,15 coprogen B,14a and α-N-methyl 
coprogen14c,16—are also known as hydroxamate-type 
siderophores. Each of these hydroxamate-type siderophores 
has a 2,5-DKP ring as a characteristic building block.17 In this 
report, we present the first synthesis of 1 as a step toward the 
certain confirmation of its full stereochemistry. 
First, we investigated the preparation of the key building block 
9 containing the 2,5-DKP ring as shown in Scheme 1. Protected 
amino acids as starting materials, α-N-Boc-δ-N-acetyl-δ-N-
benzyloxy-L-ornithine [(S)-4]11b,d and δ-N-benzyloxy-δ-N- 
(2,2,2-trichloroethoxy)carbonyl-L-ornithine methyl ester 
hydrochloride [(S)-5],11d were prepared from Boc-L-Glu(OBn)-
OH. Condensation of (S)-4 with (S)-5 using 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDCHCl) 
as a coupling reagent in the presence of 1-
hydroxybenzotriazole (HOBt) and N,N-diisopropylethylamine 
(DIPEA) furnished the N-Boc-dipeptide methyl ester 6 in 96% 
yield. We then tried a one-pot conversion of 6 into 2,5-DKP 8 
using microwave irradiation at 170 °C in a mixed solvent of 
water with methanol,11e but 8 was obtained in only moderate 
yield (58%). Therefore, we investigated a stepwise 
construction of 8. Deprotection of the Boc group of 6 with an 
excess amount of 4N HCl in dioxane afforded the dipeptide 
methyl ester hydrochloride 7 in 96% yield. Intramolecular 
cyclization of 7 on treatment with ammonia solution (2M in 
methanol) afforded the 2,5-DKP 8 in 86% yield. Then, 
reductive cleavage of the 2,2,2-trichloroethoxycarbonyl (Troc) 
group of 8 with an excess amount of zinc powder in the 
presence of 1 equivalent of trifluoroacetic acid (TFA) gave the 
key building block 9 in 76% yield. 
We attempted the condensation of 2,5-DKP 9 with two 
protected D-α-amino acids toward the synthesis of 1 (Scheme 
2). Condensation of 9 with Boc-D-Ser(OBn)-OH [(R)-10] using 
EDCHCl as a coupling reagent afforded 11. Deprotection of 
the Boc group of 11 with an excess amount of TFA provided 12 
in 74% yield (two steps). Amine 12 was coupled with α-N-Boc-
δ-N-acetyl-δ-N-benzyloxy-D-ornithine [(R)-4], which was 
prepared from Boc-D-Glu(OBn)-OH, to furnish 13 in 89% yield. 
Amine 14 was obtained by acidic deprotection of the Boc group 
of 13 in 78% yield. Acetylation of 14 with 2 equivalent of acetic 
anhydride gave 15 in 93% yield. Finally, catalytic 
hydrogenolysis of 15 under hydrogen with palladium on 
carbon (10 wt% loading) provided erythrochelin (1) in 46% 
yield by recrystallization from chloroform–methanol. The 
chemical structure of 1 was fully characterized by 
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spectroscopic methods and agreed well with the reported 1H 
and 13C NMR data.1 In addition, the negative specific rotation 
value {[α]D24 –10.3 (c 1.00, MeOH)} was observed. 
To investigate the coordination pattern of 1 with Fe(III), 
electrospray ionization mass spectrometry (ESI-MS) was used 
for the detection of metal-chelate complexes.18 As a result, 1 
was suggested to form a 1:1 complex with Fe(III) from m/z of 
679.1879 [(M–3H)+Fe(III)+Na]+ (calcd: m/z of 679.1876) in 
the presence of 1 equiv of iron(III) chloride.19 Furthermore, a 
similar 1:1 complex with Mg(II) was indicated from m/z of 
648.2449 [(M–2H)+Mg(II)+Na]+ (calcd: m/z of 648.2456) in 
the ESI-MS analysis with 1 equiv of magnesium(II) chloride.19 
In conclusion, we have achieved the synthesis of erythrochelin 
(1) and determined its specific rotation. In addition, 1 was 
found to form a 1:1 complex with not only Fe(III) but also 
Mg(II) based on ESI-MS analysis. The present work will be 
valuable for the confirmation of the full stereochemistry of 1 
isolated from Saccharopolyspora erythraea and for the 
synthesis of stereoisomers of 1 and their structurally related 
derivatives with various metal chelating abilities. 
 
 
Scheme 2  Synthesis of erythrochelin (1).
 
The experimental section has no title; please leave this line here. 
All melting points were determined on a Yanagimoto micro melting point 
apparatus and uncorrected. IR spectra were obtained using a JASCO 
FT/IR-6200 IR Fourier transform spectrometer. 1H NMR (500 MHz) and 
13C NMR (125 MHz) spectra were recorded on a Bruker AV500 
spectrometer, respectively. Chemical shifts are given in δ values (parts 
per million) using tetramethylsilane (TMS) as an internal standard. ESI-
MS were recorded on a Waters LCT Premier spectrometer. Elemental 
combustion analyses were performed using a J-SCIENCE LAB JM10. 
Microwave-assisted reaction was performed utilizing an automated 
single-mode microwave synthesizer (InitiatorTM 60; Biotage AB). All 
reactions were monitored by TLC employing 0.25-mm silica gel plates 
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(Merck 5715; 60 F254). Column chromatography was carried out on silica 
gel [Kanto Chemical 60N (spherical, neutral)]. Anhydrous CH2Cl2 was 
used as purchased from Kanto Chemical. DIPEA was distilled prior to 





To a solution of (S)-4 (498 mg, 1.31 mmol) in anhydrous CH2Cl2 (6.5 mL) 
were added HOBt (177 mg, 1.31 mmol), DIPEA (226 μL, 1.31 mmol), 
EDCHCl (376 mg, 1.96 mmol), and (S)-5 (608 mg, 1.31 mmol) at 0 °C 
under argon. The reaction mixture was allowed to warm to r.t. and 
stirred for 24 h. AcOEt (40 mL) was added to the reaction mixture, and 
then washed with 5% citric acid (10 mL), 1N HCl (10 mL), H2O (10 mL) 
and brine (10 mL). The organic layer was dried over anhydrous MgSO4, 
filtered, and concentrated in vacuo. The oily residue was purified by 
column chromatography [Silica Gel 60N: CHCl3–MeOH (50:1)] to afford 6 
(987 mg, 96%) as a colorless oil. 
[α]D20 +5.1 (c 1.00, CHCl3). 
IR (neat): 3305, 2953, 1683, 1506, 1456, 1367 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 7.46–7.32 (m, 10H), 7.12–7.00 (m, 1H), 
5.24 (brd, 1H), 4.93 (s, 2H), 4.87–4.76 (m, 4H), 4.56–4.48 (m, 1H), 4.42–
4.31 (m, 1H), 4.27–4.12 (m, 1H), 3.65 (s, 3H), 3.54 (t, J = 6.5 Hz, 2H), 
3.49–3.45 (m, 1H), 2.10 (s, 3H), 1.89–1.63 (m, 7H), 1.55–1.46 (m, 1H), 
1.43 (s, 9H). 
13C NMR (125 MHz, CDCl3): δ = 173.3, 172.4, 172.3, 155.8, 155.1, 134.8, 
134.2, 129.6, 129.2, 129.0, 128.82, 128.76, 128.5, 95.3, 79.6, 76.3, 75.1, 
52.2, 52.1, 51.7, 49.1, 43.4, 30.7, 29.2, 28.3, 23.2, 23.0, 20.4. 





trichloroethoxy)carbonyl]amino}pentanoate Hydrochloride (7) 
A mixture of 6 (1 g, 1.26 mmol) and 4N HCl in dioxane (6.3 mL, 25.3 
mmol) was stirred at r.t. for 30 min. The reaction mixture was 
concentrated in vacuo. The residue was washed with n-hexane and CHCl3 
to afford 7 (881 mg, 96%) as a white solid. 
[α]D21 +4.7 (c 1.00, CHCl3). 
IR (KBr): 3552, 3477, 3419, 3033, 2946, 2870, 1742, 1684 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 8.49 (brs, 3H), 8.26 (brd, 1H), 7.44–7.40 
(m, 2H), 7.38–7.30 (m, 8H), 4.91 (s, 2H), 4.86–4.75 (m, 4H), 4.54–4.46 
(m, 1H), 4.37 (brs, 1H), 4.02-3.87 (m, 1H), 3.69–3.47 (m, 3H), 3.59 (s, 
3H), 2.06 (s, 3H), 2.10–1.72 (m, 8H). 
13C NMR (125 MHz, CDCl3): δ = 173.4, 171.9, 169.1, 155.1, 134.8, 134.2, 
129.6, 129.3, 129.0, 128.8, 128.7, 128.5, 95.3, 77.1, 76.4, 75.2, 52.3, 52.2, 
52.0, 48.8, 43.8, 28.53, 28.47, 23.3, 22.6, 20.4. 






A mixture of 7 (53.0 mg, 0.073 mmol) and 2M NH3 in MeOH (1.46 mL, 
2.92 mmol) was stirred at r.t. for 20 h. The reaction mixture was 
concentrated in vacuo. The residue was filtered with CHCl3 and 
concentrated in vacuo. It was then purified by column chromatography 
[Silica Gel 60N: CHCl3–MeOH (15:1)] to afford 8 (41.5 mg, 86%) as a 
white solid. 
Mp 146–147 °C (white powder, MeOH) ; [α]D21 –29.8 (c 1.00, CHCl3). 
IR (KBr): 3190, 3058, 2951, 2899, 1708, 1678 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 7.44–7.32 (m, 10H), 6.88 (d, J = 1.0 Hz, 
1H), 6.67 (d, J = 1.2 Hz, 1H), 4.92 (s, 2H), 4.82 (s, 2H), 4.80 (s, 2H), 4.00–
3.91 (m, 2H), 3.73–3.58 (m, 2H), 3.57–3.45 (m, 2H), 2.07 (s, 3H), 1.95–
1.68 (m, 8H). 
13C NMR (125 MHz, CDCl3): δ = 172.7, 168.1, 167.8, 155.2, 134.8, 134.3, 
129.6, 129.2, 129.1, 128.9, 128.8, 128.6, 95.2, 76.5, 75.2, 54.5, 54.3, 49.1, 
44.6, 31.0, 30.9, 22.71, 22.67, 20.5. 
HRMS (ESI): m/z [M + Na]+ calcd for C29H35Cl3N4NaO7: 679.1469; found: 
679.1462. 
Anal. Calcd for C29H35Cl3N4O7: C, 52.94; H, 5.36; N, 8.52. Found: C, 52.87; 




To a solution of 8 (1.16 g, 1.76 mmol) and zinc (1.73 g, 26.4 mmol) in 
anhydrous CH2Cl2 (17.6 mL) was added TFA (135 μL, 1.76 mmol) at 0 °C 
under argon. The reaction mixture was allowed to warm to r.t. and 
stirred for 1.5 h. The reaction mixture was filtered with CHCl3 and 5% 
NaHCO3 (20 mL) was added to the filtrate, and then extracted with CHCl3 
(30 mL x 3). The extract was dried over anhydrous MgSO4, filtered, and 
concentrated in vacuo. The residue was purified by column 
chromatography [Silica Gel 60N: CHCl3–MeOH (20:1)] to afford 9 (650 
mg, 76%) as a white solid. 
Mp 94–95 °C ; [α]D20 –52.5 (c 1.04, CHCl3). 
IR (KBr): 3033, 2926, 2890, 1665, 1456 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 7.43–7.28 (m, 10H), 6.70 (brs, 1H), 6.44 
(brs, 1H), 5.57 (brs, 1H), 4.84–4.78 (m, 2H), 4.70 (s, 2H), 4.02–3.97 (m, 
1H), 3.91–3.85 (m, 1H), 3.74–3.58 (m, 2H), 3.00–2.89 (m, 2H), 2.09 (s, 
3H), 2.06–1.98 (m, 1H), 1.94–1.86 (m, 1H), 1.83–1.56 (m, 6H). 
13C NMR (125 MHz, CDCl3): δ = 172.5, 168.6, 168.4, 137.8, 134.3, 129.2, 
129.0, 128.7, 128.5, 128.4, 127.9, 76.4, 76.1, 54.8, 54.4, 51.3, 44.7, 32.0, 
31.1, 23.0, 22.7, 20.5. 






To a solution of 9 (530 mg, 1.10 mmol) and (R)-10 (649 mg, 2.20 mmol) 
in anhydrous CH2Cl2 (11 mL) was added EDCHCl (442 mg, 2.31 mmol) 
at 0 °C under argon. The reaction mixture was allowed to warm to r.t. 
and stirred for 1 h. AcOEt (60 mL) was added to the reaction mixture, 
and then washed with 1N HCl (20 mL), H2O (10 mL), 5% NaHCO3 (20 
mL), and brine (20 mL). The organic layer was dried over anhydrous 
MgSO4, filtered, and concentrated in vacuo. The oily residue was purified 
by column chromatography [Silica Gel 60N: CHCl3–MeOH (40:1 to 10:1)] 
to afford 11 (763 mg) as a colorless oil containing small amounts of 
impurities. In the next step, 11 was used without further purification. 
1H NMR (500 MHz, CDCl3): δ = 7.41–7.34 (m, 10H), 7.31–7.20 (m, 5H), 
6.50 (brs, 1H), 6.41 (brs, 1H), 5.49 (d, J = 8.4 Hz, 1H), 5.00 (brs, 1H), 
4.94–4.76 (m, 4H), 4.52–4.44 (m, 2H), 4.00–3.82 (m, 2H), 3.76–3.58 (m, 
5H), 3.54–3.45 (m, 1H), 2.08 (s, 3H), 1.91–1.83 (m, 1H), 1.79–1.67 (m, 
7H), 1.45 (s, 9H). 
13C NMR (125 MHz, CDCl3): δ = 172.6, 171.6, 168.0, 167.7, 155.5, 137.6, 
134.3, 133.9, 129.3, 129.2, 129.1, 129.0, 128.80, 128.76, 128.4, 127.79, 
127.77, 79.8, 76.9, 76.5, 73.1, 70.0, 54.3, 54.1, 50.8, 44.8, 44.7, 30.7, 29.9, 
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A solution of 11 (763 mg) in TFA (10 mL, 131 mmol) was stirred at r.t. 
for 30 min. The reaction mixture was concentrated in vacuo. The residue 
was dissolved in 5% NaHCO3 (40 mL) and then extracted with CHCl3 (25 
mL x 3). The extract was dried over anhydrous MgSO4, filtered, and 
concentrated in vacuo. It was then purified by column chromatography 
[Silica Gel 60N: CHCl3–MeOH (15:1)] to afford 12 (534 mg, 74%, 2 steps) 
as a colorless oil. 
[α]D20 –29.9 (c 1.00, CHCl3). 
IR (neat): 3452, 3244, 2936, 2871, 2516, 1664, 1454 cm–1. 
1H NMR (500 MHz, CDCl3): δ = 7.41–7.23 (m, 15H), 6.94 (brs, 1H), 6.90 
(brs, 1H), 4.87–4.76 (m, 4H), 4.48 (s, 2H), 4.06 (brs, 1H), 3.93 (brs, 1H), 
3.82 (brs, 1H), 3.76–3.57 (m, 5H), 3.55–3.49 (m, 1H), 2.06 (s, 3H), 1.91–
1.65 (m, 10H). 
13C NMR (125 MHz, CDCl3): δ = 175.0, 172.6, 168.1, 168.0, 137.9, 134.3, 
134.1, 129.3, 129.2, 129.1, 129.0, 128.80, 128.75, 128.4, 127.74, 127.70, 
76.6, 76.5, 73.3, 72.7, 54.3, 54.2, 51.1, 44.7, 30.8, 30.4, 22.7, 22.5, 20.5. 







To a solution of 12 (44.1 mg, 0.0668 mmol) and (R)-4 (25.4 mg, 0.0668 
mmol) in anhydrous CH2Cl2 (0.7 mL) were added EDCHCl (19.2 mg, 
0.100 mmol) and 4-dimethylaminopyridine (DMAP) (0.82 mg, 0.00668 
mmol) at 0 °C under argon. The reaction mixture was allowed to warm to 
r.t. and stirred for 24 h. AcOEt (20 mL) was added to the reaction 
mixture, and then washed with 1N HCl (5 mL), H2O (5 mL), 5% NaHCO3 
(5 mL), and brine (5 mL). The organic layer was dried over anhydrous 
MgSO4, filtered, and concentrated in vacuo. The residue was purified by 
by column chromatography [Silica Gel 60N: CHCl3–MeOH (20:1)] to 
afford 13 (60.6 mg, 89%) as a white solid. 
Mp 52–55 °C ; [α]D23 –31.9 (c 1.00, CHCl3). 
IR (KBr): 3064, 3034, 2931, 2869, 1708, 1675, 1497, 1454 cm–1. 
1H NMR (500 MHz, DMSO-d6): δ = 8.17–8.09 (m, 3H), 7.48–7.34 (m, 15H), 
7.31–7.19 (m, 5H), 6.89 (brd, 1H), 5.26–5.15 (m, 1H), 5.01–4.94 (m, 1H), 
4.89–4.82 (m, 5H), 4.44–4.35 (m, 2H), 4.08–3.99 (m, 1H), 3.84–3.75 (m, 
3H), 3.64–3.40 (m, 7H), 1.99 (s, 3H), 1.98 (s, 3H), 1.72–1.44 (m, 12H), 
1.36 (s, 9H). 
13C NMR (125 MHz, CDCl3): δ = 173.2, 173.1, 172.7, 171.1, 168.3, 167.8, 
155.8, 137.5, 134.4, 134.3, 134.1, 129.3, 129.25, 129.19, 129.06, 129.02, 
129.0, 128.8, 128.7, 128.4, 128.0, 127.8, 79.5 76.5, 76.3, 73.3, 69.2, 54.3, 
53.6, 52.6, 49.9, 44.8, 44.3, 43.9, 30.4, 29.9, 28.4, 23.0, 22.7, 22.4, 20.5. 







A solution of 13 (60.6 mg, 0.0593 mmol) in TFA (0.6 mL, 7.86 mmol) was 
stirred at r.t. for 30 min. The reaction mixture was concentrated in vacuo. 
The residue was dissolved in 5% NaHCO3 (7 mL) and then extracted with 
CHCl3 (7 mL x 3). The extract was dried over anhydrous MgSO4, filtered, 
and concentrated in vacuo. The residue was purified by column 
chromatography [Silica Gel 60N: CHCl3–MeOH (15:1)] to afford 14 (42.6 
mg, 78%) as a colorless oil. 
[α]D23 –25.8 (c 1.00, CHCl3). 
IR (neat): 3231, 2934, 2872, 1652, 1506, 1456 cm–1. 
1H NMR (500 MHz, DMSO-d6): 8.22 (brd, 1H), 8.14 (brd, 2H), 7.48–7.34 
(m, 15H), 7.32–7.18 (m, 5H), 5.25–5.16 (m, 1H), 5.02–4.94 (m, 1H), 4.90–
4.80 (m, 5H), 4.44–4.35 (m, 2H), 3.84–3.74 (m, 3H), 3.67–3.44 (m, 7H), 
3.23–3.17 (m, 1H), 1.983 (s, 3H), 1.980 (s, 3H), 1.82 (brs, 2H), 1.72–1.50 
(m, 11H), 1.39–1.28 (m, 1H). 
13C NMR (125 MHz, CDCl3): δ = 175.6, 173.7, 172.6, 171.2, 168.2, 167.7, 
137.6, 134.4, 134.3, 134.0, 129.4, 129.24, 129.19, 129.0, 128.9, 128.78, 
128.76, 128.71, 128.4, 127.9, 127.8, 76.5, 76.3, 73.1, 69.5, 54.4, 54.3, 53.8, 
49.3, 44.7, 44.4, 32.1, 30.7, 30.0, 23.2, 22.7, 22.2, 20.51, 20.48. 







To a solution of 14 (29.5 mg, 0.0320 mmol) in anhydrous CH2Cl2 (0.64 
mL) was added Ac2O (6 μL, 0.0640 mmol) at r.t. under argon. The 
reaction mixture was stirred for 40 min. AcOEt (20 mL) was added to the 
reaction mixture, and then washed with 5% NaHCO3 (5 mL x 2), H2O (5 
mL), and brine (5 mL). The organic layer was dried over anhydrous 
MgSO4, filtered, and concentrated in vacuo. The residue was purified by 
column chromatography [Silica Gel 60N: CHCl3–MeOH (20:1)] to afford 
15 (28.7 mg, 93%) as a white solid. 
Mp 65–70 °C (white powder, CHCl3–n-hexane) ; [α]D22 –34.3 (c 1.00, 
CHCl3). 
IR (KBr): 3267, 3213, 3065, 3034, 2934, 2870, 1670, 1535, 1498, 1455 
cm–1. 
1H NMR (500 MHz, DMSO-d6): δ = 8.30 (brd, 1H), 8.139 (d, J = 9.9 Hz, 1H), 
8.136 (d, J = 9.8 Hz, 1H), 7.99 (d, J = 8.4 Hz, 1H), 7.47–7.35 (m, 15H), 
7.31–7.20 (m, 5H), 5.23–5.14 (m, 1H), 5.02–4.95 (m, 1H), 4.89–4.82 (m, 
5H), 4.44–4.36 (m, 3H), 3.83–3.75 (m, 3H), 3.64–3.39 (m, 7H), 1.985 (s, 
3H), 1.978 (s, 3H), 1.83 (s, 3H), 1.72–1.42 (m, 12H). 
13C NMR (125 MHz, CDCl3): δ = 173.7, 173.4, 172.7, 171.4, 170.7, 168.9, 
168.4, 137.4, 134.3, 134.2, 129.21, 129.17, 129.1, 129.0, 128.9, 128.8, 
128.7, 128.4, 128.0, 127.9, 76.51, 76.46, 76.3, 73.4, 68.7, 54.2, 53.2, 50.4, 
44.8, 44.0, 43.4, 30.3, 29.8, 29.6, 23.2, 23.0, 22.9, 22.6, 20.5. 







A mixture of 15 (155 mg, 0.161 mmol) and 10% Pd-C (17.1 mg, 0.0161 
mmol) in MeOH (3.2 mL) was stirred at r.t. for 3.5 h under hydrogen. The 
reaction mixture was filtered and concentrated in vacuo. The residue 
was recrystallized from CHCl3–MeOH to afford erythrochelin (1) (44.7 
mg, 46%) as a hygroscopic white powder. 
[α]D24 –10.3 (c 1.00, MeOH). 
IR (KBr): 3109, 2930, 2872, 1671, 1536, 1457 cm–1. 
1H NMR (500 MHz, DMSO-d6): δ = 9.82 (brs, 1H), 9.67 (brs, 1H), 9.66 
(brs, 1H), 8.13 (brs, 1H), 8.08 (brs, 1H), 7.96 (d, J = 8.3 Hz, 1H), 7.74 (brd, 
1H), 4.92–4.85 (m, 1H), 4.78 (brt, 1H), 4.36–4.29 (m, 1H), 3.81 (brs, 2H), 
3.67–3.35 (m, 8H), 1.97 (s, 6H), 1.85 (s, 3H), 1.71–1.39 (m, 12H). 
13C NMR (125 MHz, DMSO-d6): δ = 171.5, 170.17, 170.15, 169.2, 169.1, 
167.9, 167.8, 60.8, 53.7, 53.5, 52.05, 52.03, 47.0, 46.7, 46.6, 30.2, 30.0, 
29.4, 23.0, 22.4, 22.0, 21.7, 20.2. 
HRMS (ESI): m/z [M + Na]+ calcd for C24H41N7NaO11: 626.2762; found: 
626.2762. 
 
ESI-MS Analysis of Erythrochelin (1)–Fe(III) Complex 
A solution of Fe(III)Cl3 (0.21 mg) was prepared at 0.7 μM in MeOH and 
added to an equimolar amount of 1 (0.79 mg). The mixture was further 
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diluted (1:1000 v/v) in MeOH before it was injected in the ESI source for 
MS analysis. 
 
ESI-MS Analysis of Erythrochelin (1)–Mg(II) Complex 
A solution of Mg(II)Cl2 (0.09 mg) was prepared at 0.5 μM in MeOH and 
added to an equimolar amount of 1 (0.56 mg). The mixture was further 
diluted (1:1000 v/v) in MeOH before it was injected in the ESI source for 
MS analysis. 
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